| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 3.680 | 11.134 | 11.371 | 8.818 | 20.849 | 17.731 | 23.884 | 19.797 | 13.865 |
| Total Income - EUR | 7.664 | 7.267 | 14.543 | 14.575 | 11.263 | 23.079 | 18.753 | 23.884 | 19.799 | 13.865 |
| Total Expenses - EUR | 9.748 | 14.112 | 12.094 | 8.217 | 7.761 | 19.100 | 15.058 | 18.557 | 17.647 | 16.587 |
| Gross Profit/Loss - EUR | -2.084 | -6.845 | 2.450 | 6.357 | 3.502 | 3.979 | 3.695 | 5.327 | 2.152 | -2.722 |
| Net Profit/Loss - EUR | -2.084 | -6.906 | 2.116 | 6.016 | 3.238 | 3.592 | 3.517 | 5.088 | 1.954 | -2.861 |
| Employees | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Appmed Innovation Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.744 | 13.524 | 9.815 | 6.365 | 3.746 | 1.399 | 1.368 | 1.372 | 1.368 | 1.361 |
| Current Assets | 1.398 | 2.358 | 2.726 | 1.615 | 5.117 | 7.035 | 6.847 | 8.295 | 7.916 | 3.002 |
| Inventories | 0 | 0 | 145 | 649 | 651 | 1.212 | 996 | 999 | 996 | 990 |
| Receivables | 1.381 | 1.395 | 861 | 143 | 442 | 6 | 506 | 1.524 | 660 | 1 |
| Cash | 17 | 963 | 1.721 | 823 | 4.023 | 5.816 | 5.346 | 5.772 | 6.260 | 2.011 |
| Shareholders Funds | -2.039 | -8.924 | -6.657 | -519 | 2.729 | 4.093 | 4.966 | 6.867 | 5.065 | -446 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.618 | 24.901 | 10.058 | 2.674 | 2.936 | 3.344 | 3.250 | 2.820 | 4.243 | 4.809 |
| Income in Advance | 16.657 | 12.900 | 9.272 | 5.898 | 3.339 | 1.045 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Appmed Innovation Srl